NEW YORK (AP) -- Two analysts starting covering biotech drugmaker Chimerix Inc. with top ratings on Monday, pointing to the company's experimental drug CMX001. THE OPINION: Cowen & Co. analyst Phil ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Chimerix ( (CMRX)) has shared an ...

We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where Chimerix Inc. (NASDAQ:CMRX) stands against other healthcare ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

DURHAM, NC, February 14, 2011 – Chimerix, Inc., a pharmaceutical company developing orally-available broad spectrum antiviral therapeutics, today announced the completion of a $45 million Series F ...

Shares of Chimerix Inc. shot up 14.4% in premarket trading Monday, after the biopharmaceutical company said it will sell exclusive rights to its smallpox treatment, including Tembexa, to Emergent ...

(Reuters) - Chimerix Inc said on Friday it had been awarded a contract worth up to $25.3 million by Canada for its smallpox drug, likely to used to treat monkeypox as the viral infection spreads ...

A small biotechnology company agreed yesterday to provide their experimental, antiviral drug for the treatment of a seven-year-old Virginia boy, Joshua Hardy, who is currently suffering from a ...

Social media campaigns for "compassionate use" access to drugs still in clinical trials got a big boost yesterday. The mother of Josh Hardy, a now-8-year-old boy suffering with cancer for nearly all ...

When asked whether or not he thought 7-year-old Josh Hardy should receive lifesaving treatment, a member of the board of directors at Chimerix seemed to blame government regulation for the company’s ...